The FDA has updated the safety labeling for the over-the-counter weight loss aid alli (orlistat) to include warnings about acute kidney injury.

All orlistat products will now carry a warning about kidney stones or kidney injury ...

The kidney disease approval marks Apellis' third approval in four years. (Getty Images/Rasi Bhadramani) Novartis and its Fabhalta may have been first to the punch in ultrarare kidney disease ...

Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's kidney cancer drug Welireg with its ...

The nation’s only over-the-counter weight loss drug—which has been taken by millions—could cause fatal kidney problems.

FDA issues new kidney warning for weight loss pill - Alli was the first over-the-counter weight loss pill approved by the U.S ...

AstraZeneca is looking to grow its blockbuster Farxiga brand outside of its original diabetes label and more deeply into chronic kidney disease. (Ivan-balvan/iStock ...

(RTTNews) - Novo Nordisk A/S (NVO), Thursday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has supported label update for weight-loss drug ...

More than 20 million adults in the United States have chronic kidney disease. Drugs that treat red blood cell deficiencies are critical for maintaining many chronic kidney disease patients' health.